Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children

Wiener Klinische Wochenschrift

Volumn 124, Issue 15-16, 2012, Pages 504-515

  Bedenić, Branka ^a,b   Vraneš, Jasmina ^a   Hofmann Thiel, Sabine ^c   Tonkić, Marija ^d   Novak, Anita ^d   Bučević Popovic, Viljemka ^e   Hoffmann, Harald ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

^e UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Children; Escherichia coli; Extended spectrum lactamases; Urinary tract infections; Virulence

Indexed keywords

ADHESIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; HEMOLYSIN; IMIPENEM; MEROPENEM; NETILMICIN; VANCOMYCIN;

ADAMS STOKES ATTACK; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTERIURIA; BLA GENE; BRONCHITIS; CONTROLLED STUDY; CONVULSION; ENTEROCOLITIS; FEBRILE BONE MARROW APLASIA; FEMALE; GENE SEQUENCE; GENOTYPE; HEMATURIA; HUMAN; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NEWBORN; NEWBORN SEPSIS; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; PYELONEPHRITIS; PYLORUS STENOSIS; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; UTERINE HYPOTONIA;

BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROATIA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84866247972     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0210-5     Document Type: Article

References (51)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51. (Pubitemid 32979636)
2. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med. 2005;352:380-92.
3. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1-14. (Pubitemid 38040170)
4. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases in the community. J Antimicrob Chemother. 2005;56:52-9. (Pubitemid 41418336)
5. Pallecchi L, Bartoloni A, Fiorelli C, et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low resource settings in Latina America. Antimicrob Agents Chemother. 2007;51:2720-5. (Pubitemid 47206205)
6. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordman P. Extended-spectrum ?-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother. 2007;51:2855-60. (Pubitemid 47206222)
7. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals. Antimicrob Agents Chemother. 2003;47:3724-32. (Pubitemid 37484979)
8. Pournaras S, Ikonomidis A, Kristo I, Tsakris A, Maniatis A. CTX-M enzymes are the most common extended-spectrum β-lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother. 2004;54:574-5. (Pubitemid 39177493)
9. Canton R, Oliver A, Coque TM. Epidemiology of extendedspectrum ?-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12 year period. J Clin Microbiol. 2002; 40:1237-43. (Pubitemid 34279882)
10. Yamasaki K, Komatsu M, Yamashita T. Production of CTXM- 3 extended-spectrum ?-lactamase and IMP-1 metallo- β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J Antimicrob Chemother. 2003;51:631-8. (Pubitemid 36336157)
11. Yu WL, Winokur P, Von Stein DL. First description of CTXM- β-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob Agents Chemother. 2002; 46:1098-1100. (Pubitemid 34260357)
12. Chanawong A, M'Zalli FH, Heritage J. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14 among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother. 2002;46:630-7. (Pubitemid 34157644)
13. Quinteros M, Radice M, Gardella N. Extended-spectrum β-lactamases in Buenos Aires, public hospitals. Antimicrob Agents Chemother. 2003;47:2864-7.
14. Calbo E, Romani V, Xercavins M, et al. Risk factors for community- onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother. 2006;57:780-3.
15. Delinska-Galinska A, Kurlenda J, Kozielska E, Borkowska A, Luczak G, Plata-Nazar K. Prevalence of ESBL strains in urinary tract infections in children in 1996 and 2004. Przegl Epidemiol. 2006;60:59-64.
16. Uzunović-Kamberović S, Bedenić B, Vraneš J. Predominance of SHV-5 β-lactamase in community acquired urinary tract infections. Clin Microbiol Infect. 2007;13:820-3.
17. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother. 2007;47:773-80.
18. Vranes J, Kruzic V, Sterk-Kuzmanovic N, Schoenwald S. Virulence characteristics of Escherichia coli strains causing asymptomatic bacteriuria. Infection 2003;31:216-20. (Pubitemid 36960555)
19. Vranes J. Hemagglutination ability and adherence to the Buffalo green monkey kidney cell line of uropathogenic Escherichia coli. APMIS. 1997;105:831-7. (Pubitemid 27483629)
20. Schiller NL, Hatch RA. The serum sensitivity, colony morphology, serogroup specificity, and outer membrane protein of Pseudomonas aeruginosa strains isolated from several clinical sites. Diagn Microbiol Infect Dis. 1983;1:145-7.
21. CLSI. Performance standards for antimicrobial susceptibility testing methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Eighteen informational supplement. CLSI document M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008.
22. Rasheed JK, Anderson GJ, Yigit H, et al. Characterization of the extended-spectrum ?-lactamase reference strain, Klebsiella pneumoniae K6, (ATCC 700603) which produces the novel enzyme SHV-18. Antimicrob Agents Chemother. 2000;44:2382-8. (Pubitemid 30650883)
23. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867-78.
24. Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V editor. Antibiotics in laboratory medicine. 2nd edn. Baltimore: Williams and Wilkins; 1986. p. 683-721.
25. Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV ?-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996;15:398-402. (Pubitemid 26181640)
26. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH, Philippon, A. Molecular characterization by PCR restriction fragment polymorphism of TEM b-lactamases. FEMS Microbiol Lett. 1995;134:203-8.
27. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2006;54:735-43.
28. Pagani L, Mantengoli E, Migliavacca R, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum β-lactamase in Northern Italy. J Clin Microbiol. 2004;42:2523-9. (Pubitemid 38747500)
29. Woodford N, Fagan, EJ, Ellington, MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extendedspectrum β-lactamases. J Antimicrob Chemother. 2006; 57:154-5. (Pubitemid 43057077)
30. Kaufman ME. Pulsed-field gel electrophoresis. In: Woodfor N, Johnsons A, editors. Molecular bacteriology. Protocols and clinical applications. 1st edn. New York: Humana Inc. Totowa; 1998. p. 33-51.
31. Tenover F, Arbeit R, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbio. 1995;2233-9.
32. Lee J, Pai H, Kim Y, et al. Control of extended-spectrum β- lactamase producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother. 2007;60:629.
33. Empel J, Baraniak A, Literacka E, et al. Molecular survey of b-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother. 2008; 52:2449-54. (Pubitemid 351923073)
34. Tonkić M, Goić-Barišić I, Punda-Polić V. Prevalence and antimicrobial resistance of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in a University Hospital Split. Int Microbiol. 2005; 8:119-24. (Pubitemid 41322279)
35. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G. Italian ESBL study group Occurrence of extended- spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implication for resistance to β- lactams and other antimicrobial drugs. Antimicrob Agents Chemother. 2002;46:196-202.
36. Goosens H. Mystic program: summary of European data from 1997-2000. Diagn Microbiol Infect Dis. 2001;41:183-9.
37. Yu Y, Zhou W, Chen Y, Ding Y, Ma Y. Epidemiologic and antibiotic resistance study on extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in Zhejinang Province. Chin Med J. 2002;115:1479-82. (Pubitemid 35282905)
38. Gales AC, Sader HH, Jones RH. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America; frequency of occurrence and antimicrobial susceptibility profile: results from SENTRY Antimicrobial Resistance Program (1997-2000). Diagn Microbiol Infect Dis. 2002; 44:301-11. (Pubitemid 35454105)
39. Tash H, Hakki-Bahar I. Molecular characterization of TEM and SHV-derived extended-spectrum ?-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005;58:162-7.
40. Prodinger WM, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 ?-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol. 1996;34:564-8.
41. Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 ?-lactamase among hospitalized patients. Infection 1993;21:24-8.
42. Pragai Z, Koczian Z, Nagy E. Characterization of the extended- spectrum β-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary. J Antimicrob Chemother. 1998;42:401-3. (Pubitemid 28442460)
43. Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5 type extended-spectrum β-lactamases. Antimicrob Agents Chemother. 1998;4:514-20. (Pubitemid 28114801)
44. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother. 1990;26:635-48.
45. Miranda G, Castro N, Leanos B, Valenzuela A, Garza-Ramos U, Rojas T, et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extendedspectrum ?-lactamase in a Mexican Pediatric hospital. J Clin Microbiol. 2004;42:30-5. (Pubitemid 38082695)
46. Bedenic B, Randegger C, Stobberingh E, Haechler H. Molecular epidemiology of extended-spectrum β-lactamases from Klebsiella pneumoniae strains, isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis. 2001;20:505-8. (Pubitemid 34212115)
47. Bedenic B, Schmidt H, Herold S, et al. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase in Dubrava University Hospital, Zagreb. J Chemother. 2005;17:367-75. (Pubitemid 41288224)
48. Vranić-Ladavac M, Bošnjak Z, Beader N, Bariš ić N, Kalenić S, Bedenić B. Clonal spread of CTX-M producing Klebsiella pneumoniae in Croatian hospital. J Med Microbiol. 2010;59:1069-78.
49. Bedenić B, Vraneš J, Bošnjak Z, Marijan T, Mlinarić-Džepina A, Kukovec T, Anušić M, Beader N, Barl P, Leskovar V, Kalenić S. Emergence of CTX-M group 1 extended-spectrum β- lactamase-producing Klebsiella pneumoniae strains in the community. Med Glas. 2010;1:32-9.
50. Payne DJ, Marriot MS, Amyes SGB. Characterization of a unique ceftazidime-hydrolyzing β-lactamase, TEM-E2. J Med Microbiol. 1990;12:131-4. (Pubitemid 20178819)
51. Essack S. Treatment options for extended-spectrum β-lactamase producers. FEMS Microbiol Lett. 2000;190:181-4.